Which stomach cancer surgery is easier on patients? new study aims to find out
NCT ID NCT05205343
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares symptoms, especially appetite, in patients who have one of two types of minimally invasive stomach cancer surgery: removing only the upper part of the stomach or the whole stomach. Researchers will track how patients feel using a simple questionnaire. The goal is to find out which surgery leads to a better quality of life for people with stomach or gastroesophageal junction cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Keio University School of Medicine
RECRUITINGTokyo, 1600016, Japan
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Mayo Clinic in Rochester
ACTIVE_NOT_RECRUITINGRochester, Minnesota, 55905, United States
-
Yonsei University College of Medicine
RECRUITINGSoeul, 03722, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can an immunotherapy combo shrink stomach tumors before surgery?
- Can adding immunotherapy to chemotherapy improve gastric cancer outcomes?
- Can immunotherapy outperform chemo after stomach cancer surgery?
- Can a smart drug home in on Hard-to-Treat cancers?